pharma news
The European Medicines Agency (EMA) has granted Orphan Drug Designation to Debiopharm International‘s Debio 1143 for treatment of ovarian cancer.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.